Literature DB >> 22359183

General practitioners' perceptions of pharmacists' new services in New Zealand.

Ernieda Hatah1, Rhiannon Braund, Stephen Duffull, June Tordoff.   

Abstract

BACKGROUND: In recent years, the pharmacy profession has moved towards more patient-oriented services. Some examples are medication review, screening and monitoring for disease, and prescribing. The new services are intended to be in close collaboration with general practitioners (GPs) yet little is known of how GPs in New Zealand perceive these new services. Objective To examine GPs' perceptions of pharmacists' new services.
SETTING: Study was undertaken at GPs' practices in two localities in New Zealand.
METHODS: Qualitative, face to face, semi-structured interviews were undertaken of 18 GPs. The cohort included GPs with less/more than 20 years of practice, and GPs who had experience of working in localities where some patients had undergone a medication review (Medicines Use Review, MUR) by community pharmacists. GPs were asked to share their perceptions about pharmacists providing some new services. Data were thematically analysed with constant comparison using NVivo 8 software. Using a business strategic planning approach, themes were further analysed and interpreted as the services' potential Strengths, Weaknesses, Opportunities and Threats (SWOTs). MAIN OUTCOMES MEASURE: GPs' perceptions of pharmacists' new services.
RESULTS: GPs were more supportive of pharmacists' playing active roles in medication review and less supportive of pharmacists practising screening-monitoring and prescribing. Discussions Pharmacists' knowledge and skills in medication use and the perceived benefits of the services to patients were considered the potential strengths of the services. Weaknesses centred around potential patient confusion and harm, conflict and irritation to GPs' practice, and the potential to fragment patient-care. Opportunities were the possibilities of improving communication, and having a close collaboration and integration with GPs' practice. Apparent threats were the GPs' perceptions of a related, and not renumerated, increase in their workloads, and the perception of limited benefit to patients.
CONCLUSION: Pharmacists should exploit their own strengths and the potential opportunities for these services, and reduce any weaknesses and threats. A possible strategic plan should include increased effective communication, piloting services, and the integration of some services into medical practices.

Entities:  

Mesh:

Year:  2012        PMID: 22359183     DOI: 10.1007/s11096-012-9617-3

Source DB:  PubMed          Journal:  Int J Clin Pharm


  18 in total

1.  The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and General Practioners in the United Kingdom.

Authors:  J Edmunds; M W Calnan
Journal:  Soc Sci Med       Date:  2001-10       Impact factor: 4.634

2.  Examining the first year of Medicines Use Review services provided by pharmacists in New Zealand: 2008.

Authors:  Evan Lee; Rhiannon Braund; June Tordoff
Journal:  N Z Med J       Date:  2009-04-24

3.  Physician attitudes toward pharmacist provision of medication therapy management services.

Authors:  Fadi M Alkhateeb; Kevin A Clauson; Renee McCafferty; David A Latif
Journal:  Pharm World Sci       Date:  2009-05-27

4.  The challenge of integrating community pharmacists into the primary health care team: a case study of local pharmaceutical services (LPS) pilots and interprofessional collaboration.

Authors:  Fay Bradley; Rebecca Elvey; Darren M Ashcroft; Karen Hassell; Juliette Kendall; Bonnie Sibbald; Peter Noyce
Journal:  J Interprof Care       Date:  2008-08       Impact factor: 2.338

5.  Shifts in expectations: evaluating physicians' perceptions as pharmacists become integrated into family practice.

Authors:  B Farrell; K Pottie; K Woodend; V Yao; L Dolovich; N Kennie; C Sellors
Journal:  J Interprof Care       Date:  2010-01       Impact factor: 2.338

6.  Collaborative medication management services: improving patient care.

Authors:  Andrew L Gilbert; Elizabeth E Roughead; Justin Beilby; Kathy Mott; John D Barratt
Journal:  Med J Aust       Date:  2002-08-19       Impact factor: 7.738

7.  Clinical and economic outcomes of medication therapy management services: the Minnesota experience.

Authors:  Brian J Isetts; Stephen W Schondelmeyer; Margaret B Artz; Lois A Lenarz; Alan H Heaton; Wallace B Wadd; Lawrence M Brown; Robert J Cipolle
Journal:  J Am Pharm Assoc (2003)       Date:  2008 Mar-Apr

8.  Physician perceptions of pharmacist-provided medication therapy management: qualitative analysis.

Authors:  Stephanie Harriman McGrath; Margie E Snyder; Gladys Garcia Dueñas; Janice L Pringle; Randall B Smith; Melissa Somma McGivney
Journal:  J Am Pharm Assoc (2003)       Date:  2010 Jan-Feb

9.  The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia.

Authors:  Barry A Bunting; Benjamin H Smith; Susan E Sutherland
Journal:  J Am Pharm Assoc (2003)       Date:  2008 Jan-Feb

10.  Outcomes from DiabetesCARE: a pharmacist-provided diabetes management service.

Authors:  Carrie L Johnson; Amy Nicholas; Holly Divine; Donald G Perrier; Karen Blumenschein; Douglas T Steinke
Journal:  J Am Pharm Assoc (2003)       Date:  2008 Nov-Dec
View more
  15 in total

1.  Pharmacist review and its impact on Singapore nursing homes.

Authors:  Hui Shan Chia; John Aik Hui Ho; Bernadette Daolin Lim
Journal:  Singapore Med J       Date:  2015-09       Impact factor: 1.858

Review 2.  Quasi experimental designs in pharmacist intervention research.

Authors:  Ines Krass
Journal:  Int J Clin Pharm       Date:  2016-01-29

3.  Patient, family physician and community pharmacist perspectives on expanded pharmacy scope of practice: a qualitative study.

Authors:  Maoliosa Donald; Kathryn King-Shier; Ross T Tsuyuki; Yazid N Al Hamarneh; Charlotte A Jones; Braden Manns; Marcello Tonelli; Wendy Tink; Nairne Scott-Douglas; Brenda R Hemmelgarn
Journal:  CMAJ Open       Date:  2017-03-06

4.  The expanding scope of pharmacists' practice: implications for physicians.

Authors:  Cara Tannenbaum; Ross T Tsuyuki
Journal:  CMAJ       Date:  2013-08-19       Impact factor: 8.262

5.  Qualitative study of medication review in Flanders, Belgium among community pharmacists and general practitioners.

Authors:  Anneleen Robberechts; Céline De Petter; Lindsey Van Loon; Silas Rydant; Stephane Steurbaut; Guido De Meyer; Hans De Loof
Journal:  Int J Clin Pharm       Date:  2021-01-23

6.  The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.

Authors:  Hanni Prihhastuti Puspitasari; Parisa Aslani; Ines Krass
Journal:  Int J Clin Pharm       Date:  2015-05-12

7.  Cooperation between community pharmacists and general practitioners in eastern Germany: attitudes and needs.

Authors:  Anna-Franziska Wüstmann; Carsten Haase-Strey; Thomas Kubiak; Christoph Alexander Ritter
Journal:  Int J Clin Pharm       Date:  2013-04-11

Review 8.  Reflective practice and its implications for pharmacy education.

Authors:  Cherie Tsingos; Sinthia Bosnic-Anticevich; Lorraine Smith
Journal:  Am J Pharm Educ       Date:  2014-02-12       Impact factor: 2.047

9.  Proposal for a pharmacogenetics certificate program for pharmacists.

Authors:  Susanne B Haga; Jivan Moaddeb
Journal:  Pharmacogenomics       Date:  2016-03-29       Impact factor: 2.533

10.  Medication use review in Qatar: are community pharmacists prepared for the extended professional role?

Authors:  Ahmed Hussein Babiker; Louise Carson; Ahmed Awaisu
Journal:  Int J Clin Pharm       Date:  2014-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.